ESHRE Endometriosis guideline

Question 1

The exact prevalence of endometriosis is unknown, but estimates range from ____% within the general female population but up to ___% in infertile women

Answer 1

The exact prevalence of endometriosis is unknown, but estimates range from 2 to 10% within the
general female population but up to 50% in infertile women

Question 2

How much time on average occurs between the onset of symptoms and a reliable diagnosis?

Answer 2

8-12 years

Question 4

What symptoms should make a clinician consider the diagnosis of endometriosis?

Answer 4

In individuals presenting with the following cyclical and non-cyclical signs and symptoms: dysmenorrhea, deep dyspareunia, dysuria, dyschezia, painful rectal bleeding or
haematuria, shoulder tip pain, catamenial pneumothorax, cyclical cough/haemoptysis/
chest pain, cyclical scar swelling and pain, fatigue, and infertility.

Question 5

Can you exclude endometriosis if imagine is negative?

Answer 5

a negative finding does not exclude endometriosis, particularly superficial peritoneal disease.

Question 6

What are Menopause-related major health concerns in women with endometriosis who have undergone an early
bilateral salpingo-oophorectomy as part of their treatment

Answer 6

These women have an increased risk of diminished bone density, dementia, and cardiovascular disease. It is also important to
note that women with endometriosis have an increased risk of cardiovascular disease,
irrespective of whether they have had an early surgical menopause.